Lisa Koester Wiedemann
Adult Health · Saint Louis, MONPI 1184642662
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,577 of the $13,669 with a category attached, or 84.7%. Cormedix Inc. accounts for 62.5% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $8,671, more than ten times the $20 reported in 2021. Among adult health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $804.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cormedix Inc.$9K
- Fresenius USA Marketing, Inc.$4K
- GSK$600
- Calliditas Therapeutics US Inc.$202
- Nxstage Medical, Inc.$174
- Travere Therapeutics, Inc.$125
- plus $255 from 3 others
What the payments were for
- Consulting fees$11,57785%
- Travel & lodging$8456%
- Food & beverage$1,2469%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cormedix Inc. | 2 | $8,540 |
| Fresenius USA Marketing, Inc. | 5 | $3,773 |
| GSK | 1 | $600 |
| Calliditas Therapeutics US Inc. | 2 | $202 |
| Nxstage Medical, Inc. | 3 | $174 |
| Travere Therapeutics, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $121 |
| Vifor Pharma, Inc. | 1 | $121 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DefenCath$8,500
- Korsuva$2,836
- Velphoro$938
- NXSTAGE SYSTEM ONE$131
- LIBERTY SELECT CYCLER$131
- XPHOZAH 30 MG$121
- TARPEYO$117
How this compares
$13,669 in reported general payments places this provider in the 95th percentile of 555 adult health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 15 | $10,757 |
| Sevelamer Carbonate | 21 | $2,183 |
| Furosemide | 31 | $132 |
| Pantoprazole Sodium | 12 | $108 |
| Amlodipine Besylate | 36 | $107 |
| Atorvastatin Calcium | 18 | $89 |
| Carvedilol | 15 | $75 |
Paid to pharmacies, not to this prescriber.
Other adult health in Saint Louis
- Stephanie VogelSaint Louis$115K
- Shannon TuckerSaint Louis$93K
- Laurencia KlipfelSaint Louis$79K
- Maria WallsSaint Louis$69K
- Jennifer SpeiserSaint Louis$27K
- Michele NobsSaint Louis$15K
- Erin DoserSaint Louis$13K
- Marcee StegemeierSaint Louis$12K
- Heather PophamSaint Louis$10K
- Denise ApprillSaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.